Cite
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters.
MLA
Nouailles, Geraldine, et al. “Live-Attenuated Vaccine SCPD9 Elicits Superior Mucosal and Systemic Immunity to SARS-CoV-2 Variants in Hamsters.” Nature Microbiology, vol. 8, no. 5, May 2023, pp. 860–74. EBSCOhost, https://doi.org/10.1038/s41564-023-01352-8.
APA
Nouailles, G., Adler, J. M., Pennitz, P., Peidli, S., Teixeira Alves, L. G., Baumgardt, M., Bushe, J., Voss, A., Langenhagen, A., Langner, C., Martin Vidal, R., Pott, F., Kazmierski, J., Ebenig, A., Lange, M. V., Mühlebach, M. D., Goekeri, C., Simmons, S., Xing, N., … Trimpert, J. (2023). Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters. Nature Microbiology, 8(5), 860–874. https://doi.org/10.1038/s41564-023-01352-8
Chicago
Nouailles, Geraldine, Julia M Adler, Peter Pennitz, Stefan Peidli, Luiz Gustavo Teixeira Alves, Morris Baumgardt, Judith Bushe, et al. 2023. “Live-Attenuated Vaccine SCPD9 Elicits Superior Mucosal and Systemic Immunity to SARS-CoV-2 Variants in Hamsters.” Nature Microbiology 8 (5): 860–74. doi:10.1038/s41564-023-01352-8.